Oncosec Medical (ONCS) Announces Presentation of Positive ImmunoPulse IL-12 Data in Treating Melanoma
Tweet Send to a Friend
OncoSec Medical Incorporated (NASDAQ: ONCS) presented long-term, follow-up data of patients who were treated with its investigational therapy ImmunoPulse IL-12 ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
